Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov official registry

Cellulitis clinical trials

Every US clinical trial registered for Cellulitis — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

12 US clinical trials ·

The research picture

Cellulitis has 12 registered US clinical trials; none are currently listed as recruiting, so most are completed or in follow-up.

0
recruiting participants now
0%
of trials open to enrollment
6
in Phase 3–4 (later-stage)
2
top sponsor: Melinta Therapeutics

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

ACTIVE NOT RECRUITING NA 1,080 participants

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

University of California, Los Angeles

NCT06526884

COMPLETED NA 1,634 participants

Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care

Nationwide Children's Hospital

NCT05226260

COMPLETED Phase 3 1,019 participants

Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection

Melinta Therapeutics

NCT01252732

COMPLETED Phase 3 968 participants

Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)

Melinta Therapeutics

NCT01252719

COMPLETED Phase 3 573 participants

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Durata Therapeutics Inc., an affiliate of Allergan

NCT01339091

COMPLETED 416 participants

Utility of Thermal Imaging in Diagnosis of Cellulitis for Lower Extremity Complaints in the Emergency Department

University of Wisconsin, Madison

NCT04928235

COMPLETED Phase 2 169 participants

Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Cumberland Pharmaceuticals

NCT00061633

COMPLETED Phase 4 104 participants

Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections

University of Cincinnati

NCT01549613

COMPLETED Phase 3 101 participants

Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses

University of Massachusetts, Worcester

NCT01085929

COMPLETED Phase 2 92 participants

Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage

Valleywise Health

NCT00984022

COMPLETED Phase 4 80 participants

Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

NCT00295178

COMPLETED NA 42 participants

Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis

Albert Einstein Healthcare Network

NCT01671423

Reading the Cellulitis Trial Landscape

ClinicalTrials.gov lists 12 US studies indexed under Cellulitis, and 0 of those are currently open to recruitment — roughly 0% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Cellulitis shows 6 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Cellulitis is led by Melinta Therapeutics with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 12 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Cellulitis?

PlainTrial tracks 12 US clinical trials for Cellulitis, of which 0 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Cellulitis?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →